Background: The present study was carried out to study various atherosclerotic risk factors in prediabetes and type II diabetes mellitus (DM) patients, with special reference to carotid artery intima-media thickness (CIMT). The mean value of CIMT as an indicator of early atherosclerosis was determined and the various atherosclerotic risk factors in patients with prediabetes and type II DM were studied.
INTRODUCTION
The metabolic dysregulation associated with diabetes mellitus (DM) causes secondary pathophysiological changes in multiple organ systems that impose a tremendous burden on the individual and on the health care system. Aging and rampant obesity underlie a current epidemic of type II DM. 1 People with impaired glucose tolerance (IGT) have been shown to have endothelial dysfunction and are at increased risk of cardiovascular disease (CVD). 2 Carotid intima-media thickness (CIMT) has been observed to be increased in people who would subsequently develop diabetic vascular complications due to atherosclerosis and is a major cause of morbidity and mortality in type II diabetes, atherosclerosis being a major risk factor which is accelerated in diabetes. 3 Endothelial dysfunction precedes development of atherosclerosis and plays a major role in its pathophysiology. 4 The CIMT is a surrogate marker of atherosclerosis and provides a noninvasive method for risk assessment of CVD. 5 The progression of CIMT is influenced by cardiovascular risk factors and is directly related to the risk factors of future cardiovascular events. 6 It has, therefore, become a valuable research tool in clinical trials in the assessment of therapeutic agents directed against atherosclerosis.
7
Studies have also demonstrated association of cardiovascular risk and increase in CIMT in people with prediabetes and type II diabetes.
8

MATERIALS AND METHODS
A total of 100 patients comprising 50 prediabetics and 50 type II DM patients were studied who presented to RajaRajeswari Medical College and Hospital, Bengaluru, Karnataka, India, over a period of 1 year. It was a comparative study.
AIMS AND OBJECTIVES
• To study the various atherosclerotic risk factors in patients with prediabetes and type II diabetes.
• To study the CIMT as an indicator of early atherosclerosis in patients with prediabetes and type II diabetes.
Inclusion Criteria
All patients with prediabetes defined as fasting plasma glucose (FPG) 100 to 125 mg/dL or 140 to 199 mg/dL following oral glucose challenge or hemoglobin (Hb) A1c of 5.7 to 6.4% in the age group of 30 to 65 years were included. All patients with type II DM in the age group of 30 to 65 years with no past history of atherosclerotic events with FPG > 126 mg/dL or random blood sugar >200 mg/dL or HbA1c > 6.5% were also included.
Exclusion Criteria
• Type I diabetes mellitus • Diabetes with chronic kidney disease • Diabetes with congestive cardiac failure • Diabetes with established coronary artery disease • Patients on statin therapy for more than 6 months Detailed history was taken followed by anthropometric measurements, weight, height, body mass index (BMI), and systemic examination. Biochemical tests in the form of fasting blood serum (FBS), oral glucose tolerance test, HbA1c, lipid profile, renal function test and urine micro albuminuria, echocardiography (ECG), two-dimensional ECG were observed.
The CIMT thickness measurement was done by trained professionals using high-resolution B-mode ultrasonography system having an electrical linear transducer midfrequency of 7.5 MHz on both left and right extracranial carotid arteries. The IMT is measured as the distance from the leading edge of the first echogenic line to the second echogenic line. First echogenic line -luminal intimal interface. Second echogenic line -collagen containing upper layer of intimal adventitia. At each longitudinal projection, determination of IMT was conducted at the side of greatest thickness and at two points: 1 cm upstream and 1 cm downstream. Mean of six IMT measurements was taken from both sides and cutoff was taken as 0.8 mm.
Descriptive and interferential statistical analysis was carried out. Results on continuous measurements are presented as mean ± standard deviation (SD). Significance was assessed at 5% using Student's t-test (between two groups) and Chi-square/Fisher's exact test (between two or more groups). 
RESULTS
Mean age of distribution in diabetics was 52.20 ± 9.91 years, while in prediabetics was 45.70 ± 9.81 years.
Mean CIMT in diabetic group and prediabetics was statistically significant (p < 0.001)
The CIMT has a moderate significance with the mean duration of DM being 6.64 ± 6.71 years with p = 0.015* and the mean duration of DM with CIMT > 0.8 mm is around 8.74 ± 7.40 years. It has a strong significance with total cholesterol levels, with mean levels being 185.36 ± 52.44 mg/ dL (p-value = 0.001)**; CIMT has a suggestive significance with high-density lipoprotein (HDL) levels, with mean HDL being 41.54 ± 18.65 mg/dL with p-value of 0.082
The CIMT has a strong significance with triglyceride level (TGL) with mean TGL being 267.70 ± 124.6 mg/dL (p = 0.001)** and with postprandial blood serum (PPBS) with mean being 263.40 ± 109.18 mg/dL ( p = 0.002)**.
The CIMT in prediabetic group had a positive association with low-density lipoprotein (LDL), whereas other variables could not reach statistical significance. In type II diabetes patients, BMI had a positive association with CIMT, 33% patients were overweight with a BMI > 23 kg/ m 2 . Out of 33 overweight patients, 19 patients had a CIMT of > 0.8 mm. Out of 50 diabetic patients, 27 had a CIMT > 0.8 mm. Out of those 27 patients, 10 patients (37%) had a duration of 11 to 20 years of type II DM; CIMT had a positive association with hypertension, smoking, and a moderate significance with alcohol use.
DISCUSSION
The mean age of distribution among diabetic group was 52.20 ± 9.91 years. A similar association was found by Agarwal et al, 9, 10 in which the mean age distribution among study group was 59.78 ± 8.81 years, while in a study by ArunKumar and Lokesh 11 mean age of distribution was 56.10 ± 9.03 years. The mean age of distribution in prediabetics was 45.70 ± 9.81 years. The mean duration of type II DM in our study was 6.64 ± 6.71 years. The mean duration of diabetes among the study group was 11.23 ± 6.89 years as per Agarwal et al. 9, 10 In our study, TGL levels in diabetics and prediabetics were 267.70 ± 124.6 and 193.30 ± 89.87 respectively ( concluded that there is a small but significant relationship between PPBS and CIMT. Similar findings were found in the study done by Cercillo. 18 Significant relationship exists between postprandial glucose levels and CIMT. These events, in turn, have been associated with adverse cardiovascular events, such as stroke and myocardial infarction. Since the measurement of CIMT is noninvasive, it may prove to be a useful tool, both in diagnosing potential problems and also in monitoring treatments and their outcomes.
In the prediabetes group, CIMT had a suggestive significance with LDL, with mean value being 129.68 ± 31.99 mg/dL (Table 4 ). In patients having CIMT > 0.8, the mean value was 159.67 ± 55.19 mg/dL with p-value ±0.094, but could not attain statistical significance with other parameters. In our study, CIMT has a positive association with BMI in the diabetic group, but no association was found among BMI in prediabetic group; p = 0.193; not significant (but positive association), Fisher's exact test. Out of 33 overweight patients, 19 patients had a CIMT > 0.8 mm. The BMI was associated with common carotid artery (CCA)-IMT in patients with type II DM. 19 Ciccone et al, 20 Naya et al, 21 and Poredos et al 22 found that CCA-IMT was correlated with smoking and BMI.
CONCLUSION
The study is a two-group comparative study comprising 100 patients, of which 59 are males and 41 are female patients. The CIMT which is a noninvasive marker of atherosclerosis is raised more in diabetics compared with prediabetics. Dyslipidemia was a feature in diabetic patients with increased TGL. Duration of diabetes, BMI, TGL, total cholesterol, and postprandial blood glucose levels were recognized as risk factors in diabetics, which correlated with increased CIMT, while in prediabetics BMI and LDL levels had a positive correlation. Through our study we can summarize that CIMT being a noninvasive marker of atherosclerosis should be routinely used to diagnose potential problems and treatment outcomes in type II diabetes and prediabetes, and lifestyle modifications should be adopted to prevent the conversion of prediabetics into type II diabetes. The CIMT should be included as a routine investigation due to its noninvasive status and its utility for early recognition of atherosclerosis, which will help in cardiovascular risk reduction in diabetes and prediabetes.
